In the past 4 years, many publications described a concentration-dependent deposition of
gadolinium in the brain both in adults and children, seen as high signal intensities in the …

Gadolinium-based contrast agents (GBCAs) are commonly used for enhancement in MR
imaging and have long been considered safe when administered at recommended doses …

This review summarizes 30 years of experience in the development and clinical use of
magnetic resonance (MR) contrast agents. Despite their undisputable usefulness for …

Objectives To evaluate the clinical performance of a deep learning (DL)–based method for
brain MRI exams with reduced gadolinium-based contrast agent (GBCA) dose to provide …

Objectives The aim of this study was to evaluate the pharmacokinetic (PK) profile, safety,
and efficacy of gadopiclenol, a new high-relaxivity gadolinium-based contrast agent, in …

Ever since gadolinium was found to deposit in the brain of patients with normal kidney
function by Kanda et al. in 2014, several studies have been conducted to evaluate its effect …

The introduction of paramagnetic contrast in the late 1980s constituted a paradigm shift
boosting the efficacy of magnetic resonance imaging. Due to its high magnetic moment …

The extracellular class of gadolinium-based contrast agents (GBCAs) is an essential tool for
clinical diagnosis and disease management. In order to better understand the issues …

Background: Obstructive congenital anomalies of the kidney and urinary tract have a high
risk of kidney failure if not surgically corrected. Dynamic renal scintigraphy is the gold …

Purpose To evaluate the reliability of signal intensity (SI) changes in the basal ganglia as a
supposed indicator of gadolinium deposition in the brain after repetitive application of …